WHO ICTRP trial
Autologous bone marrow-derived cells for cardioprotection during heart surgery
ISRCTN22639386 · International Standard Randomised Controlled Trial Number (ISRCTN)
Key facts
| Trial ID | ISRCTN22639386 |
|---|---|
| Public title | Autologous bone marrow-derived cells for cardioprotection during heart surgery |
| Scientific title | Autologous bone marrow-derived cells for cardioprotection during heart surgery |
| Primary sponsor | University Hospitals of Leicester NHS Trust (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Study type | Interventional |
| Phase | Not Specified |
| Countries | United Kingdom |
| Conditions | Ischaemic heart disease Circulatory System Ischaemic heart disease |
| Interventions | Patients with triple vessel coronary artery disease with or without associated significant disease of the left main stem and undergoing elective CABG surgery will be recruited for the study. Patients will be randomised at the time of… |
| Registration date | Feb 14, 2007 |
| Target size | 44 |
| Secondary IDs | 2006-006480-23;UHL Ref: 10,176 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: